The Jonathan Paul Designer Drugs exhibit is a masterful commentary on the growing underground designer drugs industry. Designer drugs are alternatives to illegal or prescription drugs that have yet to be addressed by legislation. An example would be 'bath salts,' the drug that has been loosely linked to people eating other peoples' faces last summer.
Jonathan Paul, who also goes by Desire Obtain Cherish, mixes together the worlds of high fashion and designer drugs to create a series of resin casted acrylic sculptures. Hermes, Louis Vuitton and Yves Saint Laurent all get the pharmacological treatment.
I think that Paul's work comments on how fashion and consumerism can be like a drug, or how people use drugs as readily as they change their clothes each day. Whatever the meaning, the exhibit makes you think, and that is the mark of all great art.
What's Driving This Trend
- Designer Drugs
- The trend towards legal designer drugs presents an opportunity for the pharmaceutical industry to develop and market new products that cater to those seeking unique, non-traditional experiences.
- Fashion and Drug Culture
- The intersection of fashion and drug culture presents an opportunity for innovative collaborations between fashion brands and pharmaceutical companies to create unique products and experiences.
- Alternative Consumerism
- The trend towards alternative consumerism, including the use of designer drugs, presents an opportunity for businesses to offer new and unique products that cater to an increasingly diverse demographic.
Who This Affects Most
- Pharmaceuticals
- The pharmaceutical industry could capitalize on the trend towards legal designer drugs by developing and marketing new products that cater to those seeking unique, non-traditional experiences.
- Fashion
- The fashion industry could collaborate with pharmaceutical companies to create unique products and experiences that capitalize on the trend towards fashion and drug culture.
- Consumer Goods
- The trend towards alternative consumerism presents an opportunity for businesses to offer new and unique products, such as designer drugs, that cater to an increasingly diverse demographic.
